Bridging the Healthcare Gap: Where Engineering Meets Patient Care

A Conversation with Dean Alberto Cuitiño

As our society ages we will face increasing healthcare challenges that will require advancements in engineering. These advancements will use new technologies like multi-omics, point-of-care diagnostics, and wearable monitoring. Biosensors, which facilitate the easy and accurate collection of blood-derived data, combined with biomarker data and electronic health records, will be analyzed through state-of-the-art AI algorithms to make the diagnoses needed for precision healthcare and transforming clinical practices. Come join the discussion with the Dean as we explore how engineering can address the healthcare gaps of the future.

Note that all guests must register their vehicles with Rutgers Parking here in advance of arriving on campus. 

Distinguished Panel of Experts

	Dr. Robert E. Gross, a renowned neurosurgeon and clinician-scientist, is founder and director of the NeuroTechnology Innovation Center (NTICe), a Rutgers initiative charged with advancing patient treatment through cross-disciplinary collaboration and innovation. Joint chair of the Department of Neurosurgery at Robert Wood Johnson Medical School and New Jersey Medical School of Rutgers Health and senior vice president for neurosurgical services at RWJBarnabas Health, Dr. Gross has pioneered innovative treatments for conditions such as epilepsy, Parkinson's disease, and depression.
	Komal Gurnani is a principal partner at ZS, a global management consulting and technology firm connecting data, science, governance, and human ingenuity in such areas as healthcare, finance, and travel/hospitality. Leader of ZS's immunology vertical, Ms. Gurnani brings teams together to prioritize R&D, supply chain, commercialization, and digital-led execution to accelerate and simplify the delivery of innovative drugs to patients.
	Omar A. Montero serves as senior manager, Manufacturing Science and Technology within Advanced Therapies Supply Chain at Johnson and Johnson, leading a multidisciplinary team of engineers and scientists responsible for lifecycle management changes for CARVYKTI®, the company's first commercial cell therapy asset. Mr. Montero has overseen technology transfers for initial product introductions and subsequent capacity expansions, focusing on scalable manufacturing and cross-functional execution to support reliable supply of advanced therapies to patients.
	Thomas A. Nahass, assistant clinical professor of medicine in the Department of Critical Care at Robert Wood Johnson Medical School and Physician Champion at RWJBarnabas Health, is focused on enhancing hospital and provider outcomes through improved efficiency of Electronic Health Record (EHR) workflow. Dr. Nahass's clinical interests include the data-driven practice of critical care medicine — the integration of various hospital systems to create collaboration and data tools for research in the ICU.